Equivalence Seen Between Drug Classes for HTN Monotherapy
Thiazide, thiazide-like diuretics superior to ACEi; nondihydropyridine calcium channel blockers inferior
Risk for Birth Defects Not Increased With Adalimumab
Risk for preterm delivery higher in women with RA, Crohn disease regardless of adalimumab exposure
Risk for Second Primary Malignancy Up in CLL Survivors
SPM risk higher for men and nonwhites, after chemotherapy, for recent years of diagnosis, for advanced age
Elexacaftor-Tezacaftor-Ivacaftor Efficacious for Cystic Fibrosis
Percentage of FEV1 higher at four weeks and through 24 weeks with treatment versus placebo
